TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children

PLoS One. 2015 Apr 27;10(4):e0123244. doi: 10.1371/journal.pone.0123244. eCollection 2015.

Abstract

Background: TNF-α and IFN-γ play a role in the development of mucosal damage in celiac disease (CD). Polymorphisms of TNFA and IFNG genes, as well as of the TNFRSF1A gene, encoding the TNF-α receptor 1, might underlie different inter-individual disease susceptibility over a common HLA risk background. The aims of this study were to ascertain whether five SNPs in the TNFA promoter (-1031T>C,-857C>T,-376G>A,-308G>A,-238G>A), sequence variants of the TNFRSF1A gene and IFNG +874A>T polymorphism are associated with CD in a HLA independent manner.

Methods: 511 children (244 CD, 267 controls) were genotyped for HLA, TNFA and INFG (Real Time PCR). TNFRSF1A variants were studied (DHPLC and sequence).

Results: Only the rare TNFA-1031C (OR=0.65, 95% CI:0.44-0.95), -857T (OR=0.42, 95% CI:0.27-0.65), -376A (OR=2.25, 95% CI:1.12-4.51) and -308A (OR=4.76, 95% CI:3.12-7.26) alleles were significantly associated with CD. One TNFRSF1A variant was identified (c.625+10A>G, rs1800693), but not associated with CD. The CD-correlated TNFA SNPs resulted in six haplotypes. Two haplotypes were control-associated (CCGG and TTGG) and three were CD-associated (CCAG, TCGA and CCGA). The seventeen inferred haplotype combinations were grouped (A to E) based on their frequencies among CD. Binary logistic regression analysis documented a strong association between CD and HLA (OR for intermediate risk haplotypes=178; 95% CI:24-1317; OR for high risk haplotypes=2752; 95% CI:287-26387), but also an HLA-independent correlation between CD and TNFA haplotype combination groups. The CD risk for patients carrying an intermediate risk HLA haplotype could be sub-stratified by TNFA haplotype combinations.

Conclusion: TNFA promoter haplotypes associate with CD independently from HLA. We suggest that their evaluation might enhance the accuracy in estimating the CD genetic risk.

MeSH terms

  • Adolescent
  • Case-Control Studies
  • Celiac Disease / genetics*
  • Child
  • Child, Preschool
  • Female
  • Genetic Testing
  • HLA Antigens / genetics*
  • Haplotypes*
  • Humans
  • Infant
  • Interferon-gamma / genetics
  • Male
  • Polymorphism, Single Nucleotide*
  • Promoter Regions, Genetic
  • Receptors, Tumor Necrosis Factor, Type I / genetics
  • Tumor Necrosis Factor-alpha / genetics*
  • Young Adult

Substances

  • HLA Antigens
  • IFNG protein, human
  • Receptors, Tumor Necrosis Factor, Type I
  • TNFRSF1A protein, human
  • Tumor Necrosis Factor-alpha
  • Interferon-gamma

Grants and funding

The authors have no support or funding to report.